HTA68 Strategic Implications of EU HTAR (JCA and JSC) for Global Biopharma and Biotechs: Navigating Evolving Paradigms in Market Access
Abstract
Authors
Clement Francois Shrividya Iyer Ulrike Kuchenbecker Malek Dimassi Anna Kuciara Cecile Remuzat